Clene Nanomedicine has submitted an application to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of its experimental oral therapy CNM-Au8 for people with amyotrophic lateral ...

The ALS Association has launched a nationwide campaign to help people with amyotrophic lateral sclerosis (ALS) fight insurance denials that delay or prevent access to prescribed treatments, medical ...

A novel treatment for amyotrophic lateral sclerosis (ALS) caused by mutations in a specific gene called CHCHD10 showed ...

Electrical spinal stimulation can reduce toxic TDP-43 protein aggregates in preclinical ALS mouse models, a study reports.

That’s according to a new study from Germany that found that quantifying levels of chitinases, a family of proteins linked to ...

But 16 years later, that time of always thinking about it hasn’t come. One might think that with his level of disability, ALS would consume Todd’s thoughts. In reality, the disease caused him more ...

A new AI model shows promise for predicting genetic ALS risk regardless of family history or known mutations. Capsule Networks can distinguish people with ALS from unaffected individuals, with a high ...

Ever since I met my late husband, Jeff, who died from ALS in 2020, I had wanted to go. It was a meaningful place to him; in 1995, he served as part of the Bureau of Alcohol, Tobacco, Firearms and ...

Most patients now wait more than a year for their ALS diagnosis to be confirmed.

Managing ALS goes far beyond routine doctor visits and medical checklists. Clinical metrics can track disease progression, but they fail to capture the real story: what it actually takes to navigate ...

Amyotrophic lateral sclerosis (ALS) damages the motor nerves that control voluntary movement. As the condition progresses, affected muscles, including those responsible for breathing, become weaker, ...